pirenzepine has been researched along with Acute-Phase Reaction in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Acute-Phase Reaction: An early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Olanzapine is an atypical antipsychotic that is effective in the treatment of schizophrenia." | 5.09 | Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial. ( Beasley, C; Lund, BC; Perry, PJ; Sanger, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perry, PJ | 1 |
| Lund, BC | 1 |
| Sanger, T | 1 |
| Beasley, C | 1 |
1 trial available for pirenzepine and Acute-Phase Reaction
| Article | Year |
|---|---|
Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial.
Topics: Acute-Phase Reaction; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male | 2001 |